Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 42

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04185402Phase 4Completed
Azithromycin Reduction to Reach Elimination of Trachoma
Trachoma
PrincipalinvestigatorStart date: 2021-05-29
NCT04332107Phase 3Terminated
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
COVID-19SARS-CoV-2
PrincipalinvestigatorStart date: 2020-05-22

Research Network

Collaboration Network

13 collaborators·16 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thuy Doan, MD, PhD

University of California, San Francisco

Related
4 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2

Worked with same sponsors:

Bill and Melinda Gates FoundationPfizer+3 more
Collaborated on 1 trial
Similarity Score24%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2
Similarity Score20%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

SARS-CoV-2COVID-19
Similarity Score20%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2
Similarity Score20%

Elodie Lebas, RN

University of California, San Francisco

Related
2 trials

Shared therapeutic areas:

Trachoma

Worked with same sponsors:

Institut National de Recherche Biomedicale (INRB)National Eye Institute (NEI)+2 more
Collaborated on 2 trials
Similarity Score18%

Thomas Lietman, MD

University of California, San Francisco

Related
3 trials

Shared therapeutic areas:

Trachoma

Worked with same sponsors:

Bill and Melinda Gates FoundationInstitut National de Recherche Biomedicale (INRB)+3 more
Collaborated on 1 trial
Similarity Score14%

Tom Lietman, MD

University of California, San Francisco

Related
4 trials

Shared therapeutic areas:

Trachoma

Worked with same sponsors:

Bill and Melinda Gates FoundationNational Eye Institute (NEI)+4 more
Collaborated on 1 trial
Similarity Score14%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04185402Phase 4PrincipalInvestigator

Azithromycin Reduction to Reach Elimination of Trachoma

Trachoma
Completed
NCT04332107Phase 3PrincipalInvestigator

Azithromycin for COVID-19 Treatment in Outpatients Nationwide

COVID-19SARS-CoV-2
Terminated
NCT06289647Phase 4PrincipalInvestigator

Azithromycin Reduction to Reach Elimination of Trachoma B

Trachoma
Withdrawn

All 3 trials loaded